SCN’s 2020 Research Funding Competition – now closed
Due to the rapidly evolving situation with COVID-19 and the resulting closures and changes in Canadian research institutions, the Stem Cell Network has extended the deadline for applications to its Round 2 Funding Programs until end of day May 4, 2020. SCN will continue to monitor the situation and provide further updates as necessary.
SCN is pleased to launch the second round of its national research funding competition for the 2019-22 period. The competition is comprised of three translational research programs and SCN’s new Innovation Research Program for early-career investigators. Overall, this research funding competition will inject an approximately $4M into stem cell research across Canada.
The Accelerating Clinical Translation Program: Supports multi-disciplinary research projects that are moving toward the clinic. This program will also support translational research activities (including ELSI questions) associated with an upcoming or ongoing clinical trial. Project awards will be up to $400,000.
The Fueling Biotechnology Partnerships Program: Supports academic partnerships with emerging Canadian regenerative medicine biotech companies who are working to drive an innovative stem cell-based technology or therapy into the clinic or market. Project awards will be up to $350,000.
The Innovation Research Program for Early Career Investigators: Supports early-career investigators (within the first five years of an initial academic appointment) to develop a stem cell research program with a regenerative medicine focus. This program is also open to researchers studying the ethical, legal and social implications of stem cell and regenerative medicine. Funded Projects will serve as a foundation for a longer-term translational research program. Project awards will be up to $150,000.
The Translation and Society Team Awards: Supports national teams of high-calibre, multi-disciplinary investigators to undertake ELSI (Ethical, Legal and Social Implications) research projects that focus on key opportunities and impediments to progress in the translation of innovative stem cell research. Project awards will be up to $175,000.